HP c.49_50delinsGC ;(p.F17A)

Variant ID: 16-72090103-TT-GC

NM_005143.3(HP):c.49_50delinsGC;(p.F17A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


SARS-CoV-2 Nucleocapsid Protein Targets a Conserved Surface Groove of the NTF2-like Domain of G3BP1.

Journal Of Molecular Biology
Biswal, Mahamaya M; Lu, Jiuwei J; Song, Jikui J
Publication Date: 2022-05-15

Variant appearance in text: HP: F17A
PubMed Link: 35240128
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.

Bioengineering & Translational Medicine
Kapur, Shiven S; Silverman, Adam P AP; Ye, Anne Z AZ; Papo, Niv N; Jindal, Darren D; Blumenkranz, Mark S MS; Cochran, Jennifer R JR
Publication Date: 2017-03

Variant appearance in text: HP: F17A
PubMed Link: 28516164
Variant Present in the following documents:
  • BTM2-2-081.pdf
View BVdb publication page



Features critical for membrane binding revealed by DivIVA crystal structure.

The Embo Journal
Oliva, Maria A MA; Halbedel, Sven S; Freund, Stefan M SM; Dutow, Pavel P; Leonard, Thomas A TA; Veprintsev, Dmitry B DB; Hamoen, Leendert W LW; Löwe, Jan J
Publication Date: 2010-06-16

Variant appearance in text: HP: F17A
PubMed Link: 20502438
Variant Present in the following documents:
  • Main text
View BVdb publication page